FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Furn Knapp

Research Profile

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Disorders

Co-author Network

Publications

TOP 3
Hans-Jürgen Biersack; Jan Bucerius; Samer Ezziddin; Stefan Guhlke; Furn F Knapp; Holger Palmedo; Stefan Rogenhofer; Andrej Andris; Dirk von Mallek
Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis.
Holger Palmedo; Agnieszka Manka-Waluch; Peter Albers; Ingo G H Schmidt-Wolf; Michael Reinhardt; Samer Ezziddin; Alexius Y Joe; Roland Roedel; Rolf Fimmers; Furn F Knapp; Stefan Guhlke; Hans-Jürgen Biersack
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
M A Garland; Saed Mirzadeh; C W Alexander; G J Hirtz; R W Hobbs; G A Pertmer; Furn F Knapp
Neutron flux characterization of a peripheral target position in the High Flux Isotope Reactor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Furn Knapp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Hans-Jürgen Biersack; Jan Bucerius; Samer Ezziddin; Stefan Guhlke; Furn F Knapp; Holger Palmedo; Stefan Rogenhofer; Andrej Andris; Dirk von Mallek
Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1721-6.
2003: Holger Palmedo; Agnieszka Manka-Waluch; Peter Albers; Ingo G H Schmidt-Wolf; Michael Reinhardt; Samer Ezziddin; Alexius Y Joe; Roland Roedel; Rolf Fimmers; Furn F Knapp; Stefan Guhlke; Hans-Jürgen Biersack
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2869-75.
2003: M A Garland; Saed Mirzadeh; C W Alexander; G J Hirtz; R W Hobbs; G A Pertmer; Furn F Knapp
Neutron flux characterization of a peripheral target position in the High Flux Isotope Reactor.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2003;59(1):63-72.
2003: Knut Liepe; Reiner Hliscs; Joachim Kropp; Roswitha Runge; Furn F Knapp; Wolf-Gunter Franke
Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(6):953-60.
2003: Gerrit W Sloof; Furn F Knapp; Arthur van Lingen; J Eersels; D Poldermans; JJ Bax
Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography.
Nuclear medicine communications 2003;24(4):375-81.
2003: Hein J Verberne; Gerrit W Sloof; Arnold L Beets; Anne M Murphy; Berthe L F van Eck-Smit; Furn F Knapp
125I-BMIPP and 18F-FDG uptake in a transgenic mouse model of stunned myocardium.
European journal of nuclear medicine and molecular imaging 2003;30(3):431-9.
2002: Maria Febbraio; Ella Guy; CT Coburn; Furn F Knapp; Arnold L Beets; Nada A Abumrad; Roy L Silverstein
The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36.
Molecular and cellular biochemistry 2002;239(1-2):193-7.
2002: Kimberly Buhman; Steven J Smith; Scot J Stone; Joyce J Repa; Jinny S Wong; Furn F Knapp; Betty J Burri; Robert L Hamilton; Nada A Abumrad; Robert V Farese
DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.
The Journal of biological chemistry 2002;277(28):25474-9.
2001: DW McPherson; W K Breeden; Arnold L Beets; H Luo; VK Sood; Furn F Knapp
Stereoselective synthesis, in vitro, and initial in vivo evaluation of 1-methylpiperidin-4-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IPIP): a novel radioiodinated molecular probe with high affinity for the muscarinic receptor.
Nuclear medicine and biology 2001;28(8):959-73.
2001: Fu-Du Chen; B T Hsieh; Hsin-Ell Wang; Yueh-Hsing Ou; W K Yang; J Whang-Peng; Ren-Shyan Liu; Furn F Knapp; Gann Ting; Sang-Hue Yen
Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals.
Nuclear medicine and biology 2001;28(7):835-44.
2001: Furn F Knapp; R H Spencer; Joachim Kropp
Intravascular radiation therapy with radioactive liquid-filled balloons for inhibition of restenosis after angioplasty: a new opportunity for nuclear medicine?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(9):1384-7.
2001: Shyh-Jen Wang; Wan-Yu Lin; MN Chen; JT Chen; WL Ho; Bor-Tsung Hsieh; H Huang; Lie-Hang Shen; Gann Ting; Furn F Knapp
Histologic study of effects of radiation synovectomy with Rhenium-188 microsphere.
Nuclear medicine and biology 2001;28(6):727-32.
2001: Tahar Hajri; Azeddine Ibrahimi; CT Coburn; Furn F Knapp; theodore kurtz; Michal Pravenec; Nada A Abumrad
Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy.
The Journal of biological chemistry 2001;276(26):23661-6.
2000: CT Coburn; Furn F Knapp; Maria Febbraio; Arnold L Beets; Roy L Silverstein; Nada A Abumrad
Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.
The Journal of biological chemistry 2000;275(42):32523-9.
2000: Philip J Blower; Andrew G Kettle; Michael J O'Doherty; Anthony J Coakley; Furn F Knapp
99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
European journal of nuclear medicine 2000;27(9):1405-9.
2000: Stefan Guhlke; Arnold L Beets; K Oetjen; Saed Mirzadeh; Hans-Jürgen Biersack; Furn F Knapp
Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(7):1271-8.
2000: Knut Liepe; Reiner Hliscs; Joachim Kropp; Thomas Grüning; Roswitha Runge; Rainer Koch; Furn F Knapp; Wolf-Gunter Franke
Rhenium-188-HEDP in the palliative treatment of bone metastases.
Cancer biotherapy & radiopharmaceuticals 2000;15(3):261-5.
2000: M N Hosono; Masako N Hosono; A K Mishra; Alain Faivre-Chauvet; E Gautherot; Jacques Barbet; Furn F Knapp; Jean-François Chatal
Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer.
Annals of nuclear medicine 2000;14(3):173-9.
2000: Holger Palmedo; Stefan Guhlke; Hans Bender; Johannes Sartor; Georg Schoeneich; Jörn H Risse; Frank Grünwald; Furn F Knapp; Hans-Jürgen Biersack
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
European journal of nuclear medicine 2000;27(2):123-30.
2000: Wan-Yu Lin; Jih-Fang Hsieh; Shih-Chuan Tsai; T C Yen; Shyh-Jen Wang; Furn F Knapp
A comprehensive study on the blockage of thyroid and gastric uptakes of 188Re-perrhenate in endovascular irradiation using liquid-filled balloon to prevent restenosis.
Nuclear medicine and biology 2000;27(1):83-7.
2000: DW McPherson; M Greenbaum; H Luo; Arnold L Beets; Furn F Knapp
Evaluation of Z-(R,R)-IQNP for the potential imaging of m2 mAChR rich regions of the brain and heart.
Life sciences 2000;66(10):885-96.
1999: FT Mokler; Q Lin; H Luo; DW McPherson; Arnold L Beets; A Bockisch; Joachim Kropp; Furn F Knapp
Dual-label studies with [125I]-3(R)/[131I]-3(S)-BMIPP show similar metabolism in rat tissues.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(11):1918-27.
1999: Kim A Bergström; Christer Halldin; A Savonen; Y Okubo; Jukka Hiltunen; K Nobuhara; Carl-Gunnar Swahn; Per Karlsson; D McPherson; Furn F Knapp; S Larsson; Per-Olof Schnell; Lars Farde
Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease.
European journal of nuclear medicine 1999;26(11):1482-5.
1999: DW McPherson; Furn F Knapp
A rapid and simple Sep Pak method for purification of radioiodinated IQNP, a high affinity ligand for the muscarinic receptor.
Nuclear medicine and biology 1999;26(7):859-63.
1999: DW McPherson; H Luo; Joachim Kropp; Furn F Knapp
Improved radioiodination of 1,2-dipalmitoyl-3-IPPA via a tributyltin intermediate.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;51(4):411-7.
1999: Joachim Kropp; Michael Eisenhut; K R Ambrose; Furn F Knapp; Wolf-Gunter Franke
Pharmacokinetics and metabolism of the methyl-branched fatty acid (BMIPP) in animals and humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(9):1484-91.
1999: Jesse Weinberger; Kenneth Giedd; AD Simon; Charles C Marboe; Furn F Knapp; Frieda Trichter; Howard Amols
Radioactive beta-emitting solution-filled balloon treatment prevents porcine coronary restenosis.
Cardiovascular radiation medicine 1999;1(3):252-6.
1999: Gerrit W Sloof; Frans C Visser; Emile F I Comans; JJ Bax; T Teerlink; G J van der Vusse; Furn F Knapp
Metabolism of radioiodinated fatty acid analogs in ischemic and hypoxic canine myocardium.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(7):1204-15.
1999: Wan-Yu Lin; Jih-Fang Hsieh; C P Lin; Bor-Tsung Hsieh; Gann Ting; Shyh-Jen Wang; Furn F Knapp
Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes.
Nuclear medicine and biology 1999;26(4):455-9.
1999: Furn F Knapp; Joachim Kropp
BMIPP-design and development.
International journal of cardiac imaging 1999;15(1):1-9.
1999: Furn F Knapp; Stefan Guhlke; Arnold L Beets; W Y Lin; Michael Stabin; Howard Amols; J Weinberger
Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Cardiovascular radiation medicine 1999;1(1):86-97.
1998: Furn F Knapp
Rhenium-188--a generator-derived radioisotope for cancer therapy.
Cancer biotherapy & radiopharmaceuticals 1998;13(5):337-49.
1998: Stefan Guhlke; A Schaffland; PO Zamora; Johannes Sartor; D Diekmann; Hans Bender; Furn F Knapp; Hans-Jürgen Biersack
188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling.
Nuclear medicine and biology 1998;25(7):621-31.
1998: Shyh-Jen Wang; Wan-Yu Lin; MN Chen; C S Chi; JT Chen; WL Ho; Bor-Tsung Hsieh; Lie-Hang Shen; ZT Tsai; Gann Ting; Saed Mirzadeh; Furn F Knapp
Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(10):1752-7.
1998: Vicky Caveliers; Philippe R Franken; Q Lin; FT Mokler; H Luo; Furn F Knapp
Intra-individual comparison of 3(R)-BMIPP and 3(S)-BMIPP isomers in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(10):1672-5.
1998: Jörg Kotzerke; Sabine Fenchel; Albrecht Guhlmann; Michael Stabin; M Rentschler; Furn F Knapp; Sven N Reske
Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter.
Nuclear medicine communications 1998;19(8):795-801.
1998: Philip J Blower; A S Lam; Michael J O'Doherty; Andrew G Kettle; Anthony J Coakley; Furn F Knapp
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
European journal of nuclear medicine 1998;25(6):613-21.
1998: Shyh-Jen Wang; Wan-Yu Lin; MN Chen; Bor-Tsung Hsieh; Lie-Hang Shen; ZT Tsai; Gann Ting; JT Chen; WL Ho; Saed Mirzadeh; Furn F Knapp
Rhenium-188 microspheres: a new radiation synovectomy agent.
Nuclear medicine communications 1998;19(5):427-33.
1998: M N Hosono; Masako N Hosono; PO Zamora; Stefan Guhlke; T Haberberger; Hans Bender; Furn F Knapp; Hans-Jürgen Biersack
Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice.
Annals of nuclear medicine 1998;12(2):83-8.
1998: Kim A Bergström; Christer Halldin; Jukka Hiltunen; Carl-Gunnar Swahn; H Ito; N Ginovart; Håkan Hall; DW McPherson; Furn F Knapp; S Larsson; Per-Olof Schnell; Lars Farde
Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain.
Nuclear medicine and biology 1998;25(3):209-14.
1998: Furn F Knapp; Saed Mirzadeh; Arnold L Beets; M O'Doherty; P J Blower; E S Verdera; J S Gaudiano; Joachim Kropp; J Guhlke; Holger Palmedo; Hans-Jürgen Biersack
Reactor-produced radioisotopes from ORNL for bone pain palliation.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1998;49(4):309-15.
1998: Jörg Kotzerke; M Rentschler; Gerhard Glatting; E Schneider; Michael Stabin; Furn F Knapp; Sven N Reske
[Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty].
Nuklearmedizin. Nuclear medicine 1998;37(2):68-72.
1998: Gerrit W Sloof; Frans C Visser; JJ Bax; Arthur van Lingen; J Eersels; Furn F Knapp; Gerrit J J Teule
Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(2):255-60.
1997: Gerrit W Sloof; Frans C Visser; Arthur van Lingen; JJ Bax; J Eersels; Gerrit J J Teule; Furn F Knapp
Evaluation of heart-to-organ ratios of 123I-BMIPP and the dimethyl-substituted 123I-DMIPP fatty acid analogue in humans.
Nuclear medicine communications 1997;18(11):1065-70.
1997: Q Lin; H Luo; FT Mokler; Arnold L Beets; K R Ambrose; DW McPherson; Joachim Kropp; Furn F Knapp
Effects of configuration on the myocardial uptake of radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1434-41.
1997: Gerrit W Sloof; Frans C Visser; Emile F I Comans; A B Groeneveld; JJ Bax; Machiel J van Eenige; G J van der Vusse; Furn F Knapp
Heterogeneity of DMIPP uptake and its relationship with heterogeneous myocardial blood flow.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1424-30.
1997: Wan-Yu Lin; C P Lin; S J Yeh; Bor-Tsung Hsieh; ZT Tsai; Gann Ting; T C Yen; Shyh-Jen Wang; Furn F Knapp; M G Stabin
Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
European journal of nuclear medicine 1997;24(6):590-5.
1997: PO Zamora; Hans Bender; S Gulhke; Milan Marek; Furn F Knapp; BA Rhodes; Hans-Jürgen Biersack
Pre-clinical experience with Re-188-RC-160, a radiolabeled somatostatin analog for use in peptide-targeted radiotherapy.
Anticancer research 1997;17(3B):1803-8.
1997: Furn F Knapp; Arnold L Beets; Stefan Guhlke; PO Zamora; Hans Bender; Holger Palmedo; Hans-Jürgen Biersack
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
Anticancer research 1997;17(3B):1783-95.
1997: Furn F Knapp; DW McPherson; H Luo; B Zeeburg
Radiolabeled ligands for imaging the muscarinic-cholinergic receptors of the heart and brain.
Anticancer research 1997;17(3B):1559-72.
1997: V Strijckmans; Michel Bottlaender; H Luo; Michèle Ottaviani; DW McPherson; Christian Loc'h; Chantal Fuseau; Furn F Knapp; B Mazière
Positron emission tomographic investigations of central muscarinic cholinergic receptors with three isomers of [76Br]BrQNP.
European journal of nuclear medicine 1997;24(5):475-82.
1997: Ekaterina Dadachova; Saed Mirzadeh; S V Smith; Furn F Knapp; E L Hetherington
Radiolabeling antibodies with holmium-166.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1997;48(4):477-81.
1997: PO Zamora; Milan Marek; Furn F Knapp
Preparation of 188Re-RC-160 somatostatin analog: a peptide for local/regional radiotherapy.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1997;48(3):305-9.
1997: PO Zamora; Hans Bender; Furn F Knapp; BA Rhodes; Hans-Jürgen Biersack
Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
Hybridoma 1997;16(1):85-91.
1997: BR Zeeberg; SF Boulay; VK Sood; MR Rayeq; R A Danesh; DW McPherson; Furn F Knapp
In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
Receptors & signal transduction 1997;7(1):45-54.
1996: M Hosono; M N Hosono; T Haberberger; PO Zamora; Stefan Guhlke; Hans Bender; Furn F Knapp; Hans-Jürgen Biersack
Localization of small-cell lung cancer xenografts with iodine-125-, indium-111-, and rhenium-188-somatostatin analogs.
Japanese journal of cancer research : Gann 1996;87(9):995-1000.
1996: H Luo; A Hasan; VK Sood; R C McRee; BR Zeeberg; Richard C Reba; DW McPherson; Furn F Knapp
Evaluation of 1-azabicyclo[2.2.2]oct-3-yl alpha-fluoroalkyl-alpha-hydroxy-alpha-phenylacetates as potential ligands for the study of muscarinic receptor density by positron emission tomography.
Nuclear medicine and biology 1996;23(3):267-76.
1996: S J Wang; Wan-Yu Lin; M N Chen; Bor-Tsung Hsieh; Lie-Hang Shen; Z T Tsai; Gann Ting; Furn F Knapp
Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1996;47(3):267-71.
1996: Furn F Knapp; Mark M Goodman; G Kirsch; Sven N Reske; Joachim Kropp; Hans-Jürgen Biersack; K R Ambrose; C R Lambert; A Goudonnet
Both total chain length and position of dimethyl-branching effect the myocardial uptake and retention of radioiodinated analogues of 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid (DMIPP).
Annals of nuclear medicine 1996;10(1):19-32.
1996: PO Zamora; S Gulhke; Hans Bender; D Diekmann; BA Rhodes; Hans-Jürgen Biersack; Furn F Knapp
Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue.
International journal of cancer. Journal international du cancer 1996;65(2):214-20.
1996: M R Rayeq; SF Boulay; VK Sood; DW McPherson; Furn F Knapp; BR Zeeberg
In vivo autoradiographic and dissection evaluation of isomers of 125I-labeled 1-azabicyclo[2.2.2] oct-3-yl-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IQNP).
Receptors & signal transduction 1996;6(1):13-34.
1996: BA Rhodes; C R Lambert; Milan Marek; Furn F Knapp; E B Harvey
Re-188 labelled antibodies.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1996;47(1):7-14.
1996: S J Wang; Wan-Yu Lin; M N Chen; Bor-Tsung Hsieh; Lie-Hang Shen; Z T Tsai; Gann Ting; Furn F Knapp
Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours.
European journal of nuclear medicine 1996;23(1):13-7.
1995: DW McPherson; C R Lambert; K Jahn; VK Sood; R C McRee; BR Zeeberg; Richard C Reba; Furn F Knapp
Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
Journal of medicinal chemistry 1995;38(20):3908-17.
1995: S V Smith; N Di Bartolo; Saed Mirzadeh; R M Lambrecht; Furn F Knapp; E L Hetherington
[166Dy]dysprosium/[166Ho]holmium in vivo generator.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1995;46(8):759-64.
1995: Furn F Knapp; P Franken; Joachim Kropp
Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(6):1022-30.
1995: S J Wang; Wan-Yu Lin; Bor-Tsung Hsieh; Lie-Hang Shen; Z T Tsai; Gann Ting; Furn F Knapp
Rhenium-188 sulphur colloid as a radiation synovectomy agent.
European journal of nuclear medicine 1995;22(6):505-7.
1995: Furn F Knapp; Joachim Kropp
Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives.
European journal of nuclear medicine 1995;22(4):361-81.
1994: DW McPherson; C R Lambert; Furn F Knapp
In vivo metabolic studies of the trans-(R,R) isomer of radioiodinated IQNP: a new ligand with high affinity for the M1 muscarinic-cholinergic receptor.
European journal of nuclear medicine 1994;21(12):1293-7.
1994: Joachim Kropp; Furn F Knapp; A Weyenberg; DW McPherson; K R Ambrose; A P Callahan; K von Bergmann; Hans-Jürgen Biersack
Evaluation of pancreatic lipase activity by simple urine analysis after oral administration of a new iodine-131-labeled triglyceride.
European journal of nuclear medicine 1994;21(11):1227-30.
1994: Furn F Knapp; Saed Mirzadeh
The continuing important role of radionuclide generator systems for nuclear medicine.
European journal of nuclear medicine 1994;21(10):1151-65.
1993: Furn F Knapp; Joachim Kropp; DW McPherson; K R Ambrose; C R Lambert; A P Callahan; G Kirsch; Hans-Jürgen Biersack
Site-specific/stable radioiodination of 1,2-Pal-3-IPPA: an agent for the potential clinical evaluation of pancreatic insufficiency by urine analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(6):946-52.
1993: DW McPherson; D L DeHaven-Hudkins; A P Callahan; Furn F Knapp
Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
Journal of medicinal chemistry 1993;36(7):848-54.
1993: Gerrit W Sloof; Frans C Visser; M J Eenige van; Emile F I Comans; T Teerlink; J D Herscheid; G J Van der Vusse; Furn F Knapp
Comparison of uptake, oxidation and lipid distribution of 17-iodoheptadecanoic acid, 15-(p-iodophenyl)pentadecanoic acid and 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid in normal canine myocardium.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(4):649-57.
1992: Gerrit W Sloof; Frans C Visser; T Teerlink; Emile F I Comans; M J Eenige van; G J van der Vusse; Furn F Knapp
Incorporation of radioiodinated fatty acids into cardiac phospholipids of normoxic canine myocardium.
Molecular and cellular biochemistry 1992;116(1-2):79-87.
1992: Joachim Kropp; K R Ambrose; Furn F Knapp; H P Nissen; Hans-Jürgen Biersack
Incorporation of radioiodinated IPPA and BMIPP fatty acid analogues into complex lipids from isolated rat hearts.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(3):283-8.
1992: Mark M Goodman; GW Kabalka; R C Marks; Furn F Knapp; J Lee; Y Liang
Synthesis and evaluation of radioiodinated 2-(2(RS)-aminopropyl)-5- iodothiophenes as brain imaging agents.
Journal of medicinal chemistry 1992;35(2):280-5.
1991: Joachim Kropp; James A Likungu; P G Kirchhoff; Furn F Knapp; Karl Reichmann; Sven N Reske; Hans-Jürgen Biersack
Single photon emission tomography imaging of myocardial oxidative metabolism with 15-(p-[123I]iodophenyl) pentadecanoic acid in patients with coronary artery disease and aorto-coronary bypass graft surgery.
European journal of nuclear medicine 1991;18(7):467-74.
1990: Furn F Knapp; K R Ambrose; R Dudczak; Sven N Reske; Joachim Kropp
Catabolism of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) by isolated rat hearts.
European journal of nuclear medicine 1990;16(4-6):367-8.
1989: Mark M Goodman; K H Neff; K R Ambrose; Furn F Knapp
Effect of 3-methyl-branching on the myocardial retention of radioiodinated 19-iodo-18-nonadecenoic acid analogues.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(8):813-9.
1988: A Hotze; B Briele; F Wolf; Hans-Jürgen Biersack; Furn F Knapp
Localization and activity of inflammatory bowel disease using 111In leukocyte imaging.
Nuklearmedizin. Nuclear medicine 1988;27(3):83-6.
1988: K R Ambrose; B A Owen; A P Callahan; Mark M Goodman; Furn F Knapp
Effects of fasting on the myocardial subcellular distribution and lipid distribution of terminal p-iodophenyl-substituted fatty acids in rats.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(6):695-700.
1987: K R Ambrose; B A Owen; Mark M Goodman; Furn F Knapp
Evaluation of the metabolism in rat hearts of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents.
European journal of nuclear medicine 1987;12(10):486-91.
1987: K R Ambrose; D E Rice; Mark M Goodman; Furn F Knapp
Effect of 3-methyl-branching on the metabolism in rat hearts of radioiodinated iodovinyl long chain fatty acids.
European journal of nuclear medicine 1987;13(7):374-9.
1986: Furn F Knapp; Mark M Goodman; A P Callahan; G Kirsch
Radioiodinated 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(4):521-31.
1986: Furn F Knapp; K R Ambrose; Mark M Goodman
New radioiodinated methyl-branched fatty acids for cardiac studies.
European journal of nuclear medicine 1986;12 Suppl():S39-44.
1986: Sven N Reske; Furn F Knapp; C Winkler
Experimental basis of metabolic imaging of the myocardium with radioiodinated aromatic free fatty acids.
American journal of physiologic imaging 1986;1(4):214-29.
1985: Mark M Goodman; A P Callahan; Furn F Knapp
Design, synthesis, and evaluation of omega-iodovinyl- and omega-iodoalkyl-substituted methyl-branched long-chain fatty acids.
Journal of medicinal chemistry 1985;28(6):807-15.
1985: P C Srivastava; Furn F Knapp; A P Callahan; B A Owen; GW Kabalka; K A Sastry
Myocardial imaging agents: synthesis, characterization, and evaluation of (Z)- and (Z,E)-18-[82Br]bromo-5-tellura-17-octadecenoic acids.
Journal of medicinal chemistry 1985;28(4):408-13.
1984: Mark M Goodman; G Kirsch; Furn F Knapp
Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha- and beta-methyl-branched fatty acids.
Journal of medicinal chemistry 1984;27(3):390-7.
1984: Furn F Knapp; Mark M Goodman; GW Kabalka; K A Sastry
Synthesis and evaluation of radioiodinated (E)-18-iodo-17-octadecenoic acid as a model iodoalkenyl fatty acid for myocardial imaging.
Journal of medicinal chemistry 1984;27(1):94-7.
1984: Furn F Knapp; P C Srivastava; A P Callahan; E B Cunningham; GW Kabalka; K A Sastry
Effect of tellurium position on the myocardial uptake of radioiodinated 18-iodotellura-17-octadecenoic acid analogues.
Journal of medicinal chemistry 1984;27(1):57-63.
1983: Furn F Knapp; A P Callahan; K R Ambrose; L A Ferren; T A Butler; J L Coffey
Potential tissue-imaging agents: 23-(trimethyl [117mSn]stannyl)-24-nor-5 alpha-cholan-3 beta-ol.
Journal of medicinal chemistry 1983;26(10):1535-7.
1983: Furn F Knapp; T A Butler; L A Ferren; A P Callahan; C E Guyer; J L Coffey
Synthesis and evaluation of 24-(isopropyl[75Se]seleno)chol-5-en-3 beta-ol.
Journal of medicinal chemistry 1983;26(10):1538-41.
1983: Furn F Knapp; Mark M Goodman; A P Callahan; L A Ferren; GW Kabalka; K A Sastry
New myocardial imaging agents: stabilization of radioiodine as a terminal vinyl iodide moiety on tellurium fatty acids.
Journal of medicinal chemistry 1983;26(9):1293-300.
1983: P C Srivastava; A P Callahan; E B Cunningham; Furn F Knapp
Potential cerebral perfusion agents: synthesis and evaluation of a radioiodinated vinylalkylbarbituric acid analogue.
Journal of medicinal chemistry 1983;26(5):742-6.
1982: Mark M Goodman; Furn F Knapp; A P Callahan; L A Ferren
A new, well-retained myocardial imaging agent: radioiodinated 15-(p-lodophenyl)-6-tellurapentadecanoic acid.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(10):904-8.
1982: Mark M Goodman; Furn F Knapp; A P Callahan; L A Ferren
Synthesis and biological evaluation of 17-[131I]iodo-9-telluraheptadecanoic acid, a potential imaging agent.
Journal of medicinal chemistry 1982;25(6):613-8.
1981: Furn F Knapp; K R Ambrose; A P Callahan; L A Ferren; R A Grigsby; K J Irgolic
Effects of chain length and tellurium position on the myocardial uptake of Te-123m fatty acids.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(11):988-93.
1981: Furn F Knapp; K R Ambrose; A P Callahan
Potential pancreatic imaging agents. Tellurium-123m labeled DL-alpha-amino-gamma-(phenyltelluro)butyric acid.
Journal of medicinal chemistry 1981;24(7):794-7.
1980: D V Woo; Furn F Knapp; K R Ambrose; A P Callahan; J L Coffey
Radiation dosimetry of two new tellurium- 123m-labeled adrenal-imaging agents: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(5):454-8.
1980: Furn F Knapp; K R Ambrose; A P Callahan
Tellurium- 123m-labeled 23-(isopropyl telluro)-24-nor-5 alpha-cholan-3 beta-ol: a new potential adrenal imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(3):251-7.